The Molecular Biology Program consists of fourteen faculty who span the academic ranks, including a number who are new to MSKCC. The group has strong peer reviewed grant support from R01s and other funding mechanisms. The areas of emphasis are gene expression involving DNA synthesis and transcriptional mechanisms, and regulatory mechanisms involved in organismal development and cell differentiation. Understanding these processes is fundamental to our knowledge of growth control and carcinogenesis. The membership of the Replication and Transcription Group remain gnerally stable. The new members of the Developmental Biology Group are located in proximity to each other and to the Drosophila breeding facility. Three of the new members have been supported by the core grant. Many of the seven member Developmental Biology Group meet weekly in a journal club setting and share collaborative projects. It is envisioned that one or two more staff will be hired in the developmental biology area. There is a weekly Work-in-Progress luncheon meeting of the program at which members from within or from other programs or institutions speak. The Cell Biology and Molecular Biology Programs have a combined weekly graduate student research seminar. There is a yearly program retreat. Statements of collaborative interactions between Drs. Marians and Shuman on topoisomerases, between Drs. Marian, Massague and Hurwitz on DNA replication and some other minor interactions are presented.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA008748-37
Application #
6563635
Study Section
Project Start
2002-01-30
Project End
2002-12-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
37
Fiscal Year
2002
Total Cost
$157,506
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Meyer, Jan-Philip; Tully, Kathryn M; Jackson, James et al. (2018) Bioorthogonal Masking of Circulating Antibody-TCO Groups Using Tetrazine-Functionalized Dextran Polymers. Bioconjug Chem 29:538-545
McFarland, Daniel C; Shaffer, Kelly; Breitbart, William et al. (2018) C-reactive protein and its association with depression in patients receiving treatment for metastatic lung cancer. Cancer :
Lacouture, Mario E; Anadkat, Milan; Jatoi, Aminah et al. (2018) Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review. Clin Colorectal Cancer 17:85-96
Blumenthal, Gideon M; Bunn Jr, Paul A; Chaft, Jamie E et al. (2018) Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer. J Thorac Oncol 13:1818-1831
Shaffer, Kelly M; Nelson, Christian J; DuHamel, Katherine N (2018) Barriers to participation in a sexual health intervention for men following treatment for rectal and anal cancer. Psychooncology 27:1082-1085
Park, Kay J; Patel, Prusha; Linkov, Irina et al. (2018) Observations on the origin of ovarian cortical inclusion cysts in women undergoing risk-reducing salpingo-oophorectomy. Histopathology 72:766-776
Pianko, Matthew J; Goldberg, Aaron D; Lesokhin, Alexander M (2018) Clinical Development of PD-1 Blockade in Hematologic Malignancies. Cancer J 24:31-35
Navi, Babak B; Marshall, Randolph S; Bobrow, Dylan et al. (2018) Enoxaparin vs Aspirin in Patients With Cancer and Ischemic Stroke: The TEACH Pilot Randomized Clinical Trial. JAMA Neurol 75:379-381
Shah, Sona; Boucai, Laura (2018) Effect of Age on Response to Therapy and Mortality in Patients With Thyroid Cancer at High Risk of Recurrence. J Clin Endocrinol Metab 103:689-697
Goldman, Debra A; Hovinga, Koos; Reiner, Anne S et al. (2018) The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis. J Neurosurg :1-9

Showing the most recent 10 out of 8799 publications